Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.062 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |